Since tumors have higher STING activation and consequently more local type I IFN production compared to normal tissue54, tumor sites should be more sensitive to targeting USP18. Furthermore, inducing ICD by targeting USP18 should prompt the release of DAMPs, resulting in more IFN production. The gene discussed is USP18; the disease is neoplasm.